Assessment of immunogenicity and efficacy of a Zika vaccine using modified vaccinia Ankara virus as carriers
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has spread to more than 70 countries worldwide since 2015. Despite active research, there are currently no licensed vaccines or therapeutics. We have previously reported the development of various adenoviral vectored vaccine candidates...
Հիմնական հեղինակներ: | López-Camacho, C, Kim, Y, Abbink, P, Larocca, R, Huiskonen, J, Barouch, D, Reyes-Sandoval, A |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
MDPI
2019
|
Նմանատիպ նյութեր
-
Assessment of Immunogenicity and Efficacy of a Zika Vaccine Using Modified Vaccinia Ankara Virus as Carriers
: César López-Camacho, և այլն
Հրապարակվել է: (2019-11-01) -
Safety and immunogenicity of DNA/modified vaccinia virus ankara malaria vaccination in African adults.
: Moorthy, V, և այլն
Հրապարակվել է: (2003) -
New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
: Alharbi, N
Հրապարակվել է: (2014) -
Clinical development of Modified Vaccinia virus Ankara vaccines.
: Gilbert, S
Հրապարակվել է: (2013) -
Clinical development of Modified Vaccinia virus Ankara vaccines
: Gilbert, S
Հրապարակվել է: (2013)